The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12209121 B1

Date of Patent:

Jan. 28, 2025

Filed:

Feb. 08, 2023

Anti-sclerostin antibodies and methods of use

Applicant:

Chugai Seiyaku Kabushiki Kaisha, Tokyo, JP;

Inventor:

Zenjiro Sampei, Singapore, SG;

Assignee:

CHUGAI SEIYAKU KABUSHIKI KAISHA, Tokyo, JP;

Attorney:

Nixon & Vanderhye P.C.

Primary Examiner:

Xiaozhen Xie

Int. Cl.

CPC ...

C07K 16/46 (2006.01); A61K 39/395 (2006.01); A61P 19/08 (2006.01); C07K 16/22 (2006.01); A61K 38/00 (2006.01);

U.S. Cl.

CPC ...

C07K 16/22 (2013.01); A61K 39/395 (2013.01); A61K 39/3955 (2013.01); A61P 19/08 (2018.01); C07K 16/46 (2013.01); C07K 16/461 (2013.01); A61K 38/00 (2013.01); C07K 2317/24 (2013.01); C07K 2317/31 (2013.01); C07K 2317/515 (2013.01); C07K 2317/56 (2013.01); C07K 2317/76 (2013.01); C07K 2317/77 (2013.01); C07K 2317/92 (2013.01); C07K 2317/94 (2013.01);

Abstract

The present invention provides anti-sclerostin antibodies and methods of using the same. In some embodiments, an isolated anti-sclerostin antibody of the present invention is a multispecific antibody. The present invention also provides isolated nucleic acids encoding an anti-sclerostin antibody of the present invention. The present invention also provides host cells comprising a nucleic acid of the present invention. The present invention also provides a method of producing an antibody comprising culturing a host cell of the present invention so that the antibody is produced. The present invention also provides a pharmaceutical formulation comprising an anti-sclerostin antibody of the present invention and a pharmaceutically acceptable carrier.

Find Patent Forward Citations